Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study. Issue 5 (2nd February 2021)
- Record Type:
- Journal Article
- Title:
- Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study. Issue 5 (2nd February 2021)
- Main Title:
- Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study
- Authors:
- Toyoda, Masao
Murata, Takashi
Saito, Nobumichi
Kimura, Moritsugu
Takahashi, Hiroo
Ishida, Naoto
Kitamura, Makoto
Hida, Miho
Hayashi, Akinori
Moriguchi, Ibuki
Kobayashi, Naoyuki
Tsuriya, Daisuke
Sakao, Yukitoshi
Matsushita, Takaya
Ito, Yukie
Suzuki, Shota
Kasama, Shu
Kasahara, Masato
Yamakawa, Tadashi
Mori, Katsuhito
Kuroda, Akio
Miura, Junnosuke
Hirota, Yushi
Abe, Masanori
Fukagawa, Masafumi
Sakane, Naoki
Hosoda, Kiminori - Abstract:
- Abstract: FreeStyle Libre has been approved for use in patients undergoing hemodialysis (HD) in Japan, unlike Europe and the United States; however, evidence regarding its accuracy in such patients is sparse. Forty‐one participants with type 2 diabetes undergoing HD were recruited. The overall mean absolute relative difference and mean absolute difference were 23.4% and 33.9 mg/dL, respectively. Sensor glucose levels and capillary glucose levels were significantly correlated ( r = 0.858, P < .01), although the sensor glucose levels were significantly lower than the capillary glucose levels. The accuracy of FreeStyle Libre in patients undergoing HD became deteriorated with the days of usage. The percentage of sensor results in Zones A and B in the consensus error grid analysis and in the Clarke error grid analysis were 99.7% and 99.0%, respectively. Its insufficient accuracy necessitates adjunct usage of FreeStyle Libre with self‐monitoring of blood glucose in patients undergoing HD.
- Is Part Of:
- Therapeutic apheresis and dialysis. Volume 25:Issue 5(2021)
- Journal:
- Therapeutic apheresis and dialysis
- Issue:
- Volume 25:Issue 5(2021)
- Issue Display:
- Volume 25, Issue 5 (2021)
- Year:
- 2021
- Volume:
- 25
- Issue:
- 5
- Issue Sort Value:
- 2021-0025-0005-0000
- Page Start:
- 586
- Page End:
- 594
- Publication Date:
- 2021-02-02
- Subjects:
- accuracy -- continuous glucose monitoring -- diabetic nephropathy -- FreeStyle Libre -- hemodialysis -- type 2 diabetes
Hemapheresis -- Periodicals
Dialysis -- Periodicals
Blood Component Removal -- Periodicals
Renal Dialysis -- Periodicals
Hémaphérèse -- Périodiques
Dialyse -- Périodiques
Sang -- Collecte et conservation -- Périodiques
616 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1744-9979;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1744-9987 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=tap ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/rd.asp?code=TAP&goto=journal ↗ - DOI:
- 10.1111/1744-9987.13618 ↗
- Languages:
- English
- ISSNs:
- 1744-9979
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8814.642670
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23905.xml